Carson Wealth (CWM LLC)’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71K Buy
53,794
+47,591
+767% +$85.1K ﹤0.01% 3537
2025
Q4
$12K Buy
6,203
+2,063
+50% +$3.96K ﹤0.01% 4469
2025
Q3
$5K Buy
4,140
+1,865
+82% +$2.53K ﹤0.01% 4747
2025
Q2
$3K Buy
2,275
+765
+51% +$883 ﹤0.01% 4796
2025
Q1
$2K Sell
1,510
-491
-25% -$753 ﹤0.01% 4794
2024
Q4
$4K Buy
2,001
+1,880
+1,554% +$3.67K ﹤0.01% 4343
2024
Q3
$0 Sell
121
-1,246
-91% -$2.05K ﹤0.01% 5060
2024
Q2
$2K Buy
1,367
+1,338
+4,614% +$2.7K ﹤0.01% 4245
2024
Q1
$0 Sell
29
-161
-85% -$943 ﹤0.01% 4630
2023
Q4
$2K Sell
190
-133
-41% -$1.09K ﹤0.01% 3828
2023
Q3
$3K Buy
323
+93
+40% +$1.06K ﹤0.01% 3693
2023
Q2
$3K Buy
230
+28
+14% +$340 ﹤0.01% 3675
2023
Q1
$2K Buy
202
+82
+68% +$815 ﹤0.01% 3684
2022
Q4
$1K Buy
+120
New +$1.03K ﹤0.01% 3804
2022
Q2
Sell
-17
Closed 4020
2022
Q1
$0 Sell
17
-2
-11% -$23 ﹤0.01% 3776
2021
Q4
$0 Buy
+19
New +$459 ﹤0.01% 3608

Other funds holding PACB

Carson Wealth (CWM LLC)'s PACB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Pacific Biosciences (PACB) stake by 767% in Q1 2026, buying an estimated $85.1K and bringing the position to 53,794 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #3537.

Carson Wealth (CWM LLC) first reported a position in PACB in Q4 2021 and has held it in 16 quarters since. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 53,794 shares of Pacific Biosciences worth $71K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 47,591 Pacific Biosciences shares in Q1 2026, an estimated $85.1K.
  • Pacific Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3537 holding.
  • Carson Wealth (CWM LLC) first reported a position in Pacific Biosciences in Q4 2021 and has held it in 16 quarters since.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.